West Nile virus

[1]  Gourab Mukherjee,et al.  Single cell mass cytometry reveals remodeling of human T cell phenotypes by varicella zoster virus. , 2015, Methods.

[2]  Susan Holmes,et al.  Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility , 2015, Science Translational Medicine.

[3]  Ash A. Alizadeh,et al.  Large-Scale and Comprehensive Immune Profiling and Functional Analysis of Normal Human Aging , 2015, PloS one.

[4]  M. Katze,et al.  Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression. , 2015, Cell host & microbe.

[5]  Michael Poidinger,et al.  Mapping the Diversity of Follicular Helper T Cells in Human Blood and Tonsils Using High-Dimensional Mass Cytometry Analysis. , 2015, Cell reports.

[6]  G. Nolan,et al.  Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy , 2015, Arthritis Research & Therapy.

[7]  Hongmin Li,et al.  5'-Silylated 3'-1,2,3-triazolyl Thymidine Analogues as Inhibitors of West Nile Virus and Dengue Virus. , 2015, Journal of medicinal chemistry.

[8]  Qiang Chen.  Plant‐made vaccines against West Nile virus are potent, safe, and economically feasible , 2015, Biotechnology journal.

[9]  K. Morita,et al.  The efficacy of inactivated West Nile vaccine (WN-VAX) in mice and monkeys , 2015, Virology Journal.

[10]  R. Rappuoli,et al.  Lessons from Reverse Vaccinology for viral vaccine design. , 2015, Current opinion in virology.

[11]  Ruth R. Montgomery,et al.  CyTOF supports efficient detection of immune cell subsets from small samples. , 2014, Journal of immunological methods.

[12]  Mark M. Davis,et al.  A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory , 2014, Science Translational Medicine.

[13]  Stuart B. Goodman,et al.  Clinical recovery from surgery correlates with single-cell immune signatures , 2014, Science Translational Medicine.

[14]  Jung Eun Cho,et al.  Comparison of Four Serological Tests for Detecting Antibodies to Japanese Encephalitis Virus after Vaccination in Children , 2014, Osong public health and research perspectives.

[15]  S. Cohen,et al.  miRNAs and aging: A genetic perspective , 2014, Ageing Research Reviews.

[16]  Pauline E. Chugh,et al.  Toll-Like Receptor-3 Is Dispensable for the Innate MicroRNA Response to West Nile Virus (WNV) , 2014, PloS one.

[17]  A. Pera,et al.  Shaping of NK cell subsets by aging. , 2014, Current opinion in immunology.

[18]  F. Bai,et al.  Delivery of antiviral small interfering RNA with gold nanoparticles inhibits dengue virus infection in vitro. , 2014, The Journal of general virology.

[19]  Ruth R. Montgomery,et al.  Effect of aging on microRNAs and regulation of pathogen recognition receptors. , 2014, Current opinion in immunology.

[20]  N. Prow,et al.  Mechanism of West Nile Virus Neuroinvasion: A Critical Appraisal , 2014, Viruses.

[21]  R. Tibshirani,et al.  Automated identification of stratifying signatures in cellular subpopulations , 2014, Proceedings of the National Academy of Sciences.

[22]  D. Smee,et al.  In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus , 2014, Archives of Virology.

[23]  R. Yusof,et al.  Current approaches in antiviral drug discovery against the Flaviviridae family. , 2014, Current pharmaceutical design.

[24]  Zuofeng Li,et al.  Complement-Related Proteins Control the Flavivirus Infection of Aedes aegypti by Inducing Antimicrobial Peptides , 2014, PLoS pathogens.

[25]  Michael Engle,et al.  Generation and Analysis of Novel Plant-Derived Antibody-Based Therapeutic Molecules against West Nile Virus , 2014, PloS one.

[26]  C. Klein,et al.  Glycoengineering of Therapeutic Antibodies Enhances Monocyte/Macrophage-Mediated Phagocytosis and Cytotoxicity , 2014, The Journal of Immunology.

[27]  Yikun Gao,et al.  RVG-peptide-linked trimethylated chitosan for delivery of siRNA to the brain. , 2014, Biomacromolecules.

[28]  Justin M. Richner,et al.  Vaccination of Mice Using the West Nile Virus E-Protein in a DNA Prime-Protein Boost Strategy Stimulates Cell-Mediated Immunity and Protects Mice against a Lethal Challenge , 2014, PloS one.

[29]  Fuchun Zhang,et al.  Transmission-Blocking Antibodies against Mosquito C-Type Lectins for Dengue Prevention , 2014, PLoS pathogens.

[30]  K. Yoshii,et al.  Increased Pathogenicity of West Nile Virus (WNV) by Glycosylation of Envelope Protein and Seroprevalence of WNV in Wild Birds in Far Eastern Russia , 2013, International journal of environmental research and public health.

[31]  T. Monath,et al.  Preclinical and Clinical Development of a YFV 17 D-Based Chimeric Vaccine against West Nile Virus , 2013, Viruses.

[32]  P. Wright,et al.  The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naïve adult volunteers. , 2013, Vaccine.

[33]  Hongmin Li,et al.  The flavivirus protease as a target for drug discovery , 2013, Virologica Sinica.

[34]  Paul W Smith,et al.  Ten years of dengue drug discovery: progress and prospects. , 2013, Antiviral research.

[35]  D. Smee,et al.  Favipiravir (T-705), a novel viral RNA polymerase inhibitor. , 2013, Antiviral research.

[36]  B. Milošević,et al.  Outbreak of West Nile virus infection among humans in Serbia, August to October 2012. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[37]  Gary E. Swan,et al.  Genetic and Environmental Determinants of Human NK Cell Diversity Revealed by Mass Cytometry , 2013, Science Translational Medicine.

[38]  D. Smee,et al.  Synergistic combinations of favipiravir and oseltamivir against wild-type pandemic and oseltamivir-resistant influenza A virus infections in mice. , 2013, Future virology.

[39]  I. Ferlenghi,et al.  Structural vaccinology: a three-dimensional view for vaccine development. , 2013, Current topics in medicinal chemistry.

[40]  B. Coutard,et al.  Development of specific dengue virus 2'-O- and N7-methyltransferase assays for antiviral drug screening. , 2013, Antiviral research.

[41]  T. Welte,et al.  Role of Natural Killer and Gamma-Delta T cells in West Nile Virus Infection , 2013, Viruses.

[42]  Y. Lam,et al.  Synthesis and in vitro Evaluation of West Nile Virus Protease Inhibitors Based on the 1,3,4,5‐Tetrasubstituted 1H‐Pyrrol‐2(5H)‐one Scaffold , 2013, ChemMedChem.

[43]  D. Schols,et al.  Sulfated Escherichia coli K5 Polysaccharide Derivatives Inhibit Dengue Virus Infection of Human Microvascular Endothelial Cells by Interacting with the Viral Envelope Protein E Domain III , 2013, PloS one.

[44]  Chun-ching Lin,et al.  Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry , 2013, BMC Microbiology.

[45]  Sean C. Bendall,et al.  viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia , 2013, Nature Biotechnology.

[46]  William G. Davis,et al.  Identification of cis-Acting Nucleotides and a Structural Feature in West Nile Virus 3′-Terminus RNA That Facilitate Viral Minus Strand RNA Synthesis , 2013, Journal of Virology.

[47]  M. Ng,et al.  A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodies , 2013, Virology Journal.

[48]  Jeffrey Hill,et al.  Novel agmatine dipeptide inhibitors against the West Nile virus NS2B/NS3 protease: a P3 and N-cap optimization study. , 2013, European journal of medicinal chemistry.

[49]  M. Altfeld,et al.  Control of human viral infections by natural killer cells. , 2013, Annual review of immunology.

[50]  Rong Li,et al.  NMR Analysis of a Novel Enzymatically Active Unlinked Dengue NS2B-NS3 Protease Complex* , 2013, The Journal of Biological Chemistry.

[51]  Susan A. Jones,et al.  Selective inhibition of the West Nile virus methyltransferase by nucleoside analogs. , 2013, Antiviral research.

[52]  Pei-Yong Shi,et al.  Conformational Flexibility of the Dengue Virus RNA-Dependent RNA Polymerase Revealed by a Complex with an Inhibitor , 2013, Journal of Virology.

[53]  M. Groschup,et al.  Pathogenesis of West Nile virus lineage 1 and 2 in experimentally infected large falcons. , 2013, Veterinary microbiology.

[54]  L. Kramer,et al.  Replication of West Nile virus, Rabensburg lineage in mammalian cells is restricted by temperature , 2012, Parasites & Vectors.

[55]  D. Dimitrov,et al.  Candidate Antibody-Based Therapeutics Against HIV-1 , 2012, BioDrugs.

[56]  Justin M. Richner,et al.  A Hydrogen Peroxide-Inactivated Virus Vaccine Elicits Humoral and Cellular Immunity and Protects against Lethal West Nile Virus Infection in Aged Mice , 2012, Journal of Virology.

[57]  H. Rothan,et al.  Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1 , 2012, BMC Infectious Diseases.

[58]  E. Damonte,et al.  Antiviral activity against dengue virus of diverse classes of algal sulfated polysaccharides. , 2012, International journal of biological macromolecules.

[59]  H. Liao,et al.  HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design. , 2012, Trends in microbiology.

[60]  J. Mascola,et al.  Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies. , 2012, Immunity.

[61]  Ruth R. Montgomery,et al.  IL-22 Signaling Contributes to West Nile Encephalitis Pathogenesis , 2012, PloS one.

[62]  Alicia M. Hanson,et al.  Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. , 2012, The Journal of antimicrobial chemotherapy.

[63]  G. Lushington,et al.  Inhibitors of Dengue virus and West Nile virus proteases based on the aminobenzamide scaffold. , 2012, Bioorganic & medicinal chemistry.

[64]  Alicia M. Hanson,et al.  Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays , 2012, Nucleic acids research.

[65]  M. Tewari,et al.  MicroRNA profiling: approaches and considerations , 2012, Nature Reviews Genetics.

[66]  Anis Larbi,et al.  The immune system in the aging human , 2012, Immunologic Research.

[67]  David C. Chang,et al.  2′-O Methylation of Internal Adenosine by Flavivirus NS5 Methyltransferase , 2012, PLoS pathogens.

[68]  E. van Rooij,et al.  Developing microRNA therapeutics. , 2012, Circulation research.

[69]  J. Rolland,et al.  Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer. , 2012, Nano letters.

[70]  A. Barrett,et al.  Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness. , 2011, Vaccine.

[71]  G. Castellani,et al.  Seroprevalence of West Nile virus-specific antibodies in a cohort of blood donors in northeastern Italy. , 2011, Vector borne and zoonotic diseases.

[72]  H. Garg,et al.  Targeting HIV-1 gp41-induced fusion and pathogenesis for anti-viral therapy. , 2011, Current topics in medicinal chemistry.

[73]  Bimo Ario Tejo,et al.  Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus , 2011, BMC Bioinformatics.

[74]  C. Terrosi,et al.  Retrospective diagnosis of West Nile virus infection in a patient with meningoencephalitis in Tuscany, Italy. , 2011, Vector borne and zoonotic diseases.

[75]  C. Boye,et al.  Usutu virus in Africa. , 2011, Vector borne and zoonotic diseases.

[76]  David W Smith,et al.  West nile virus (Kunjin subtype) disease in the northern territory of Australia--a case of encephalitis and review of all reported cases. , 2011, The American journal of tropical medicine and hygiene.

[77]  A. Brault,et al.  North American West Nile virus genotype isolates demonstrate differential replicative capacities in response to temperature. , 2011, The Journal of general virology.

[78]  M. Niedrig,et al.  Second external quality assessment of the molecular diagnostic of West Nile virus: are there improvements towards the detection of WNV? , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[79]  A. Tenório,et al.  Phylogenetic relationships of Western Mediterranean West Nile virus strains (1996-2010) using full-length genome sequences: single or multiple introductions? , 2011, The Journal of general virology.

[80]  M. Capobianchi,et al.  Human case of autochthonous West Nile virus lineage 2 infection in Italy, September 2011. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[81]  G. Ippolito,et al.  West Nile virus: the Italian national transplant network reaction to an alert in the north-eastern region, Italy 2011. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[82]  S. Vasudevan,et al.  Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease. , 2011, Antiviral research.

[83]  E. Fikrig,et al.  prM-antibody renders immature West Nile virus infectious in vivo. , 2011, The Journal of general virology.

[84]  P. Calistri,et al.  2009 West Nile disease epidemic in Italy: first evidence of overwintering in Western Europe? , 2011, Research in veterinary science.

[85]  J. Saiz,et al.  West Nile Virus Replication Requires Fatty Acid Synthesis but Is Independent on Phosphatidylinositol-4-Phosphate Lipids , 2011, PloS one.

[86]  Sean C. Bendall,et al.  Extracting a Cellular Hierarchy from High-dimensional Cytometry Data with SPADE , 2011, Nature Biotechnology.

[87]  S. Günther,et al.  Isolation of usutu virus in Germany. , 2011, The American journal of tropical medicine and hygiene.

[88]  R. Neghina,et al.  Reemergence of human infections with West Nile virus in Romania, 2010: an epidemiological study and brief review of the past situation. , 2011, Vector borne and zoonotic diseases.

[89]  N. Delaroque,et al.  A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII. , 2011, Vaccine.

[90]  G. Palù,et al.  Human cases of West Nile Virus infection in north-eastern Italy, 15 June to 15 November 2010. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[91]  Ruchi M. Newman,et al.  Molecular evolution of West Nile virus in a northern temperate region: Connecticut, USA 1999-2008. , 2011, Virology.

[92]  P. Calistri,et al.  Usutu virus in Italy: an emergence or a silent infection? , 2011, Veterinary microbiology.

[93]  A. Chaskopoulou,et al.  Evidence of enzootic circulation of West Nile virus (Nea Santa-Greece-2010, lineage 2), Greece, May to July 2011. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[94]  R. Bartenschlager,et al.  Exploitation of cellular pathways by Dengue virus. , 2011, Current opinion in microbiology.

[95]  A. Papa,et al.  Detection of West Nile virus lineage 2 in mosquitoes during a human outbreak in Greece. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[96]  K. Bhardwaj,et al.  A Cell-Based Assay for RNA Synthesis by the HCV Polymerase Reveals New Insights on Mechanism of Polymerase Inhibitors and Modulation by NS5A , 2011, PloS one.

[97]  E. Wherry,et al.  A Role for the Chemokine RANTES in Regulating CD8 T Cell Responses during Chronic Viral Infection , 2011, PLoS pathogens.

[98]  A. Barrett,et al.  Immune responses to an attenuated West Nile virus NS4B-P38G mutant strain. , 2011, Vaccine.

[99]  E. Kopel,et al.  Surveillance of West Nile virus disease, Tel Aviv district, Israel, 2005 to 2010. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[100]  B. Powers,et al.  Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain. , 2011, Vaccine.

[101]  S. Margosiak,et al.  Small Molecule Pan-Dengue and West Nile Virus NS3 Protease Inhibitors , 2011, Antiviral chemistry & chemotherapy.

[102]  C. Rhee,et al.  West Nile virus encephalitis acquired via liver transplantation and clinical response to intravenous immunoglobulin: case report and review of the literature , 2011, Transplant infectious disease : an official journal of the Transplantation Society.

[103]  Amanda J. Panella,et al.  Laboratory testing practices for West Nile virus in the United States. , 2011, Vector borne and zoonotic diseases.

[104]  R. Bellini,et al.  Detection of Usutu virus within a West Nile virus surveillance program in Northern Italy. , 2011, Vector borne and zoonotic diseases.

[105]  J. Mascola,et al.  A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial. , 2011, The Journal of infectious diseases.

[106]  Erin F. Simonds,et al.  Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum , 2011, Science.

[107]  M. Diamond,et al.  Beta Interferon Controls West Nile Virus Infection and Pathogenesis in Mice , 2011, Journal of Virology.

[108]  E. Ferenczi,et al.  Equine encephalomyelitis outbreak caused by a genetic lineage 2 West Nile virus in Hungary. , 2011, Journal of veterinary internal medicine.

[109]  J. Smit,et al.  Partial maturation: an immune-evasion strategy of dengue virus? , 2011, Trends in microbiology.

[110]  Guillaume Castel,et al.  Phage Display of Combinatorial Peptide Libraries: Application to Antiviral Research , 2011, Molecules.

[111]  L. Kramer,et al.  Inhibition of Dengue Virus through Suppression of Host Pyrimidine Biosynthesis , 2011, Journal of Virology.

[112]  P. Mason,et al.  Repeated In Vivo Stimulation of T and B Cell Responses in Old Mice Generates Protective Immunity against Lethal West Nile Virus Encephalitis , 2011, The Journal of Immunology.

[113]  Massimo Ciccozzi,et al.  Phylogeography and epidemiological history of West Nile virus genotype 1a in Europe and the Mediterranean basin. , 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[114]  R. Hoop,et al.  Emergence and establishment of Usutu virus infection in wild and captive avian species in and around Zurich, Switzerland--genomic and pathologic comparison to other central European outbreaks. , 2011, Veterinary microbiology.

[115]  M. Farcet,et al.  Increasing West Nile virus antibody titres in central European plasma donors from 2006 to 2010. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[116]  P. Murphy,et al.  Chemokine control of West Nile virus infection. , 2011, Experimental cell research.

[117]  G. Palù,et al.  Prevalence of IgM and IgG antibodies to West Nile virus among blood donors in an affected area of north-eastern Italy, summer 2009. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[118]  M. Altfeld,et al.  DCs and NK cells: critical effectors in the immune response to HIV-1 , 2011, Nature Reviews Immunology.

[119]  S. Rees,et al.  Principles of early drug discovery , 2011, British journal of pharmacology.

[120]  D. Beasley.  Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus. , 2011, Immunotherapy.

[121]  S. Green,et al.  Development of antigen-specific memory CD8+ T cells following live-attenuated chimeric West Nile virus vaccination. , 2011, The Journal of infectious diseases.

[122]  J. Sejvar,et al.  West nile virus RNA not detected in urine of 40 people tested 6 years after acute West Nile virus disease. , 2011, The Journal of infectious diseases.

[123]  G. Rock.  A comparison of methods of pathogen inactivation of FFP , 2011, Vox sanguinis.

[124]  R. Goodrich,et al.  Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light , 2011, Transfusion Medicine and Hemotherapy.

[125]  Lily Lin,et al.  Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood SystemTM , 2011, Transfusion Medicine and Hemotherapy.

[126]  P. Hellstern,et al.  The Use of Solvent/Detergent Treatment in Pathogen Reduction of Plasma , 2011, Transfusion Medicine and Hemotherapy.

[127]  A. Tenório,et al.  Outbreak of West Nile virus infection in humans, Romania, July to October 2010. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[128]  X. Hua,et al.  Serological evidence of West Nile virus in dogs and cats in China , 2011, Archives of Virology.

[129]  P. Mason,et al.  Immunogenicity of RepliVAX WN, a novel single-cycle West Nile virus vaccine. , 2010, Vaccine.

[130]  Ruth R. Montgomery,et al.  A paradoxical role for neutrophils in the pathogenesis of West Nile virus. , 2010, The Journal of infectious diseases.

[131]  A. Barrett,et al.  Phylogeography of West Nile Virus: from the Cradle of Evolution in Africa to Eurasia, Australia, and the Americas , 2010, Journal of Virology.

[132]  R. Bellini,et al.  Evidence of Simultaneous Circulation of West Nile and Usutu Viruses in Mosquitoes Sampled in Emilia-Romagna Region (Italy) in 2009 , 2010, PloS one.

[133]  Gang Wang,et al.  Small Molecule Inhibitors That Selectively Block Dengue Virus Methyltransferase* , 2010, The Journal of Biological Chemistry.

[134]  S. Inoue,et al.  Development and evaluation of a formalin-inactivated West Nile Virus vaccine (WN-VAX) for a human vaccine candidate. , 2010, Vaccine.

[135]  Hongping Dong,et al.  2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members , 2010, Nature.

[136]  C. Rinaldo,et al.  Demographic and clinical factors associated with persistent symptoms after West Nile virus infection. , 2010, The American journal of tropical medicine and hygiene.

[137]  Li-Hsin Chen,et al.  microRNA and aging: A novel modulator in regulating the aging network , 2010, Ageing Research Reviews.

[138]  L. Petersen,et al.  West Nile fever characteristics among viremic persons identified through blood donor screening. , 2010, The Journal of infectious diseases.

[139]  Johannes Ottl,et al.  Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads , 2010, Expert opinion on drug discovery.

[140]  P. Calistri,et al.  Further spread of West Nile virus in Italy. , 2010, Veterinaria italiana.

[141]  M. Groschup,et al.  West Nile virus monitoring of migratory and resident birds in Germany. , 2010, Vector borne and zoonotic diseases.

[142]  C. Castilletti,et al.  West Nile virus--neutralizing antibodies in humans in Greece. , 2010, Vector borne and zoonotic diseases.

[143]  R. Swanepoel,et al.  West Nile virus lineage 2 as a cause of zoonotic neurological disease in humans and horses in southern Africa. , 2010, Vector borne and zoonotic diseases.

[144]  P. Armstrong,et al.  Studies on Hibernating Populations of Culex pipiens from a West Nile Virus Endemic Focus in New York City: Parity Rates and Isolation of West Nile Virus , 2010, Journal of the American Mosquito Control Association.

[145]  Manoj N. Krishnan,et al.  A C-Type Lectin Collaborates with a CD45 Phosphatase Homolog to Facilitate West Nile Virus Infection of Mosquitoes , 2010, Cell.

[146]  Shui-Tein Chen,et al.  The ubiquitin-proteasome pathway is important for dengue virus infection in primary human endothelial cells. , 2010, Journal of proteome research.

[147]  R. Xue,et al.  Experimental Studies on Comparison of the Potential Vector Competence of Four Species of Culex Mosquitoes in China to Transmit West Nile Virus , 2010, Journal of medical entomology.

[148]  G. Ippolito,et al.  Retrospective screening of solid organ donors in Italy, 2009, reveals unpredicted circulation of West Nile virus. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[149]  A. Papa,et al.  Ongoing outbreak of West Nile virus infections in humans in Greece, July-August 2010. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[150]  L. Visser,et al.  Case report: West-Nile virus infection in two Dutch travellers returning from Israel. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[151]  Michael S Roberts,et al.  Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice. , 2010, Small.

[152]  A. di Caro,et al.  Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[153]  J. Mackenzie,et al.  The Endoplasmic Reticulum Provides the Membrane Platform for Biogenesis of the Flavivirus Replication Complex , 2010, Journal of Virology.

[154]  Ying-Ting Lin,et al.  A cell-based reporter assay for inhibitor screening of hepatitis C virus RNA-dependent RNA polymerase. , 2010, Analytical biochemistry.

[155]  G. Jennings,et al.  A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice , 2010, Virology Journal.

[156]  P. Shi,et al.  Characterization of Dengue Virus Resistance to Brequinar in Cell Culture , 2010, Antimicrobial Agents and Chemotherapy.

[157]  B. Ferko,et al.  Influenza virus-like particles as an antigen-carrier platform for the ESAT-6 epitope of Mycobacterium tuberculosis. , 2010, Journal of virological methods.

[158]  I. Unlu,et al.  Detection of West Nile Virus RNA in Mosquitoes and Identification of Mosquito Blood Meals Collected at Alligator Farms in Louisiana , 2010, Journal of medical entomology.

[159]  M. Landini,et al.  False-Positive Transcription-Mediated Amplification Assay Detection of West Nile Virus in Blood from a Patient with Viremia Caused by an Usutu Virus Infection , 2010, Journal of Clinical Microbiology.

[160]  Valorie D. Bowman,et al.  Influence of pr-M Cleavage on the Heterogeneity of Extracellular Dengue Virus Particles , 2010, Journal of Virology.

[161]  T. Ishikawa,et al.  Evaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infection. , 2010, The American journal of tropical medicine and hygiene.

[162]  N. Becker,et al.  Mosquito-Borne West Nile Virus (WNV) Surveillance in the Upper Rhine Valley, Germany , 2010, Journal of vector ecology : journal of the Society for Vector Ecology.

[163]  M. Diamond,et al.  Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice , 2010, Virology Journal.

[164]  A. Giovannini,et al.  Epidemiology of west nile in europe and in the mediterranean basin. , 2010, The open virology journal.

[165]  M. Groschup,et al.  Sentinel birds in wild-bird resting sites as potential indicators for West Nile virus infections in Germany , 2010, Archives of Virology.

[166]  P. Calistri,et al.  West Nile Virus Transmission in 2008 in North‐Eastern Italy , 2010, Zoonoses and public health.

[167]  W. Hochachka,et al.  Ecological determinants of American crow mortality due to West Nile virus during its North American sweep , 2010, Oecologia.

[168]  S. Vasudevan,et al.  Flexibility between the Protease and Helicase Domains of the Dengue Virus NS3 Protein Conferred by the Linker Region and Its Functional Implications , 2010, The Journal of Biological Chemistry.

[169]  J. E. Staples,et al.  Surveillance for human West Nile virus disease - United States, 1999-2008. , 2010, Morbidity and mortality weekly report. Surveillance summaries.

[170]  Y. Eshita,et al.  Glycosylation of the West Nile Virus envelope protein increases in vivo and in vitro viral multiplication in birds. , 2010, The American journal of tropical medicine and hygiene.

[171]  P. Desprès,et al.  Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2',5'-oligoadenylate synthetase 1b. , 2010, Virology.

[172]  S. Pillemer,et al.  Safety and Pharmacokinetics of Single Intravenous Dose of MGAWN1, a Novel Monoclonal Antibody to West Nile Virus , 2010, Antimicrobial Agents and Chemotherapy.

[173]  P. Halbur,et al.  Susceptibility of fox squirrels (Sciurus niger) to West Nile virus by oral exposure. , 2010, Vector borne and zoonotic diseases.

[174]  P. Niyomrattanakit,et al.  Inhibition of Dengue Virus Polymerase by Blocking of the RNA Tunnel , 2010, Journal of Virology.

[175]  A. Tenório,et al.  Putative New Lineage of West Nile Virus, Spain , 2010, Emerging infectious diseases.

[176]  M. Diamond,et al.  Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice , 2010, Proceedings of the National Academy of Sciences.

[177]  W. Born,et al.  Characteristics of IL-17-producing gammadelta T cells. , 2010, Immunity.

[178]  P. Shenkin,et al.  Novel inhibitors of dengue virus methyltransferase: discovery by in vitro-driven virtual screening on a desktop computer grid. , 2010, Journal of medicinal chemistry.

[179]  A. Barrett,et al.  The NS5 Protein of the Virulent West Nile Virus NY99 Strain Is a Potent Antagonist of Type I Interferon-Mediated JAK-STAT Signaling , 2010, Journal of Virology.

[180]  Z. Hubálek,et al.  Zoonotic mosquito-borne flaviviruses: worldwide presence of agents with proven pathogenicity and potential candidates of future emerging diseases. , 2010, Veterinary microbiology.

[181]  S. Ahuja,et al.  Double-edged genetic swords and immunity: lesson from CCR5 and beyond. , 2010, The Journal of infectious diseases.

[182]  D. Follmann,et al.  CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission. , 2010, The Journal of infectious diseases.

[183]  B. Guy,et al.  Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses. , 2010, Vaccine.

[184]  J. Smit,et al.  Immature Dengue Virus: A Veiled Pathogen? , 2010, PLoS pathogens.

[185]  F. Scaravilli,et al.  Neuronal and glial cerebrospinal fluid protein biomarkers are elevated after West Nile Virus infection , 2010, Muscle & nerve.

[186]  M. Fearon,et al.  West Nile virus in 2006 and 2007: the Canadian Blood Services' experience , 2009, Transfusion.

[187]  Zhengrong Zhu,et al.  Review Article: High-Throughput Affinity-Based Technologies for Small-Molecule Drug Discovery , 2009, Journal of biomolecular screening.

[188]  B. Geiss,et al.  The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure. , 2009, RNA.

[189]  P. Shi,et al.  A small molecule fusion inhibitor of dengue virus. , 2009, Antiviral research.

[190]  C. Wiley,et al.  Key role of T cell defects in age-related vulnerability to West Nile virus , 2009, The Journal of experimental medicine.

[191]  M. G. Ciufolini,et al.  West Nile virus transmission with human cases in Italy, August - September 2009. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[192]  Ruth R. Montgomery,et al.  IL-10 Signaling Blockade Controls Murine West Nile Virus Infection , 2009, PLoS pathogens.

[193]  A. Strongin,et al.  Structure-activity relationship and improved hydrolytic stability of pyrazole derivatives that are allosteric inhibitors of West Nile Virus NS2B-NS3 proteinase. , 2009, Bioorganic & medicinal chemistry letters.

[194]  C. King,et al.  School-based health promotion for mosquito-borne disease prevention in children. , 2009, The Journal of pediatrics.

[195]  J. Harbison,et al.  Evaluation of Manhole Inserts as Structural Barriers to Mosquito Entry into Belowground Stormwater Systems Using a Simulated Treatment Device , 2009, Journal of the American Mosquito Control Association.

[196]  T. Ishikawa,et al.  RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters. , 2009, Vaccine.

[197]  Steven A. Ogata,et al.  Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine in Rhesus Monkeys , 2009, Clinical and Vaccine Immunology.

[198]  M. Diamond.  Progress on the development of therapeutics against West Nile virus. , 2009, Antiviral research.

[199]  J. Roehrig,et al.  Nocodazole delays viral entry into the brain following footpad inoculation with West Nile virus in mice , 2009, Journal of NeuroVirology.

[200]  G. Palù,et al.  West Nile virus infection in Veneto region, Italy, 2008-2009. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[201]  J. Mackenzie,et al.  The Zoonotic Flaviviruses of Southern, South‐Eastern and Eastern Asia, and Australasia: The Potential for Emergent Viruses , 2009, Zoonoses and public health.

[202]  Shuliu Zhang,et al.  Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus. , 2009, The Journal of infectious diseases.

[203]  M. Ramanathan,et al.  Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII. , 2009, Vaccine.

[204]  P. Tomasulo,et al.  West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual‐donation nucleic acid testing , 2009, Transfusion.

[205]  B. Biggerstaff,et al.  A modeling framework for evaluation and comparison of trigger strategies for switching from minipool to individual‐donation testing for West Nile virus , 2009, Transfusion.

[206]  P. Shi,et al.  Cyclosporine Inhibits Flavivirus Replication through Blocking the Interaction between Host Cyclophilins and Viral NS5 Protein , 2009, Antimicrobial Agents and Chemotherapy.

[207]  J. Pawęska,et al.  Lineage 2 West Nile Virus as Cause of Fatal Neurologic Disease in Horses, South Africa , 2009, Emerging infectious diseases.

[208]  E. Jacoby,et al.  A Small-Molecule Dengue Virus Entry Inhibitor , 2009, Antimicrobial Agents and Chemotherapy.

[209]  A. Brault,et al.  Comparative thermostability of West Nile, St. Louis encephalitis, and western equine encephalomyelitis viruses during heat inactivation for serologic diagnostics. , 2009, The American journal of tropical medicine and hygiene.

[210]  M. Venter,et al.  A highly sensitive method for the detection and genotyping of West Nile virus by real-time PCR. , 2009, Journal of virological methods.

[211]  Martino Bolognesi,et al.  Flaviviral methyltransferase/RNA interaction: Structural basis for enzyme inhibition , 2009, Antiviral Research.

[212]  D. Kuritzkes.  HIV-1 entry inhibitors: an overview , 2009, Current opinion in HIV and AIDS.

[213]  C. Broder,et al.  Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses , 2009, Expert opinion on biological therapy.

[214]  A. Brault.  Changing patterns of West Nile virus transmission: altered vector competence and host susceptibility , 2009, Veterinary research.

[215]  A. Porgador,et al.  Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection , 2009, BMC infectious diseases.

[216]  Martin J. Stoermer,et al.  Structure of West Nile virus NS3 protease: ligand stabilization of the catalytic conformation. , 2009, Journal of molecular biology.

[217]  R. Koski,et al.  A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells. , 2009, Vaccine.

[218]  David Beer,et al.  Discovery of a Non-Peptidic Inhibitor of West Nile Virus NS3 Protease by High-Throughput Docking , 2009, PLoS neglected tropical diseases.

[219]  N. Pattabiraman,et al.  Identification and Biochemical Characterization of Small-Molecule Inhibitors of West Nile Virus Serine Protease by a High-Throughput Screen , 2009, Antimicrobial Agents and Chemotherapy.

[220]  R. Kuhn,et al.  Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein. , 2008, ACS chemical biology.

[221]  C. Apetrei,et al.  Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01 , 2008, Vaccine.

[222]  J. Votýpka,et al.  Spread of the West Nile virus vector Culex modestus and the potential malaria vector Anopheles hyrcanus in central Europe , 2008, Journal of vector ecology : journal of the Society for Vector Ecology.

[223]  P. Calistri,et al.  Phylogenetic analysis of West Nile virus isolated in Italy in 2008. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[224]  O. V. Platonova,et al.  Epidemiology of West Nile infection in Volgograd, Russia, in relation to climate change and mosquito (Diptera: Culicidae) bionomics , 2008, Parasitology Research.

[225]  A. Pletnev,et al.  Attenuated West Nile viruses bearing 3'SL and envelope gene substitution mutations. , 2008, Vaccine.

[226]  C. Spak,et al.  West Nile virus encephalitis in a renal transplant recipient: the role of intravenous immunoglobulin. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[227]  E. Hayes,et al.  West Nile virus in the Americas. , 2008, The Medical clinics of North America.

[228]  A. Sampath,et al.  Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target. , 2008, Antiviral research.

[229]  Z. Hubálek,et al.  Serologic survey of birds for West Nile flavivirus in southern Moravia (Czech Republic). , 2008, Vector borne and zoonotic diseases.

[230]  H. Malet,et al.  The flavivirus polymerase as a target for drug discovery. , 2008, Antiviral research.

[231]  D. Fremont,et al.  The structural immunology of antibody protection against West Nile virus , 2008, Immunological reviews.

[232]  Hongping Dong,et al.  Flavivirus methyltransferase: a novel antiviral target. , 2008, Antiviral research.

[233]  A. di Caro,et al.  West Nile virus in Italy: a further threat to blood safety, a further challenge to the blood system. , 2008, Blood transfusion = Trasfusione del sangue.

[234]  James F. Jones,et al.  Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. , 2008, Journal of neuropsychology.

[235]  M. Ng,et al.  Inhibition of West Nile virus replication in cells stably transfected with vector-based shRNA expression system. , 2008, Virus research.

[236]  B. Solheim.  Pathogen reduction of blood components. , 2008, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[237]  Z. Hubálek,et al.  Serologic survey of potential vertebrate hosts for West Nile virus in Poland. , 2008, Viral immunology.

[238]  P. D. de Sessions,et al.  West Nile Virus Nonstructural Protein 1 Inhibits TLR3 Signal Transduction , 2008, Journal of Virology.

[239]  Laura D. Kramer,et al.  Temperature, Viral Genetics, and the Transmission of West Nile Virus by Culex pipiens Mosquitoes , 2008, PLoS pathogens.

[240]  T. Ishikawa,et al.  Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system. , 2008, Vaccine.

[241]  N. Green,et al.  Cell-based assays to identify inhibitors of viral disease , 2008, Expert opinion on drug discovery.

[242]  R. Rappuoli,et al.  Genome‑based vaccine development: A short cut for the future , 2008, Human vaccines.

[243]  Eric Vivier,et al.  Functions of natural killer cells , 2008, Nature Immunology.

[244]  David C. Chang,et al.  Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus , 2008, Nature Biotechnology.

[245]  Jianguo Wu,et al.  Inhibition of west nile virus replication by retrovirus‐delivered small interfering RNA in human neuroblastoma cells , 2008, Journal of medical virology.

[246]  E. Fikrig,et al.  Extrinsic Incubation Periods for Horizontal and Vertical Transmission of West Nile Virus by Culex pipiens pipiens (Diptera: Culicidae) , 2008, Journal of medical entomology.

[247]  L. Xing,et al.  Crystallization and preliminary X-ray diffraction analysis of recombinant hepatitis E virus-like particle. , 2008, Acta crystallographica. Section F, Structural biology and crystallization communications.

[248]  M. Rossmann,et al.  The Flavivirus Precursor Membrane-Envelope Protein Complex: Structure and Maturation , 2008, Science.

[249]  Michael Schmidt,et al.  West Nile virus and blood product safety in Germany , 2008, Journal of medical virology.

[250]  Å. Lundkvist,et al.  A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis. , 2008, The Journal of infectious diseases.

[251]  H. Ellerbrok,et al.  Assessing the exposure of German and Austrian bird ringers to West Nile virus (Flavivirus) and evaluating their potential risk of infection , 2008, Journal of Ornithology.

[252]  R. Koski,et al.  Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus. , 2007, The Journal of infectious diseases.

[253]  V. Luzhkov,et al.  Virtual screening and bioassay study of novel inhibitors for dengue virus mRNA cap (nucleoside-2'O)-methyltransferase. , 2007, Bioorganic & medicinal chemistry.

[254]  W. Marasco,et al.  The growth and potential of human antiviral monoclonal antibody therapeutics , 2007, Nature Biotechnology.

[255]  G. Ebel,et al.  Crow Deaths Caused by West Nile Virus during Winter , 2007, Emerging infectious diseases.

[256]  H. Ellerbrok,et al.  Detection of West Nile virus lineages 1 and 2 by real-time PCR. , 2007, Journal of virological methods.

[257]  Martin H. Koldijk,et al.  Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine. , 2007, Vaccine.

[258]  A. Osterhaus,et al.  Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus , 2007, Vaccine.

[259]  John F Anderson,et al.  Nocturnal Activity of Mosquitoes (Diptera: Culicidae) in a West Nile Virus Focus in Connecticut , 2007, Journal of medical entomology.

[260]  D. R. Mercer,et al.  Spatiotemporal Investigation of Adult Mosquito (Diptera: Culicidae) Populations in an Eastern Iowa County, USA , 2007, Journal of medical entomology.

[261]  R. De Francesco,et al.  Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. , 2007, Advanced drug delivery reviews.

[262]  P. Hendrikx,et al.  West Nile virus outbreak detection using syndromic monitoring in horses. , 2007, Vector borne and zoonotic diseases.

[263]  Ruth R. Montgomery,et al.  Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. , 2007, The Journal of clinical investigation.

[264]  O. Pluquet,et al.  Dengue virus serotype infection specifies the activation of the unfolded protein response , 2007, Virology Journal.

[265]  C. J. Bennett,et al.  Mosquitoes Inoculate High Doses of West Nile Virus as They Probe and Feed on Live Hosts , 2007, PLoS pathogens.

[266]  E. Holmes,et al.  A single positively selected West Nile viral mutation confers increased virogenesis in American crows , 2007, Nature Genetics.

[267]  C. Seeger,et al.  Differential Effects of Mutations in NS4B on West Nile Virus Replication and Inhibition of Interferon Signaling , 2007, Journal of Virology.

[268]  F. Conraths,et al.  Serologic evidence of West Nile virus infections in wild birds captured in Germany. , 2007, The American journal of tropical medicine and hygiene.

[269]  T. Scott,et al.  Geographic variation in vector competence for West Nile virus in the Culex pipiens (Diptera: Culicidae) complex in California. , 2007, Vector borne and zoonotic diseases.

[270]  P. Shi,et al.  Interaction between the Cellular Protein eEF1A and the 3′-Terminal Stem-Loop of West Nile Virus Genomic RNA Facilitates Viral Minus-Strand RNA Synthesis , 2007, Journal of Virology.

[271]  B. Davidson,et al.  Transvascular delivery of small interfering RNA to the central nervous system , 2007, Nature.

[272]  A. Brault,et al.  West Nile virus in North America: perspectives on epidemiology and intervention. , 2007, Pest management science.

[273]  Evgeny M. Zdobnov,et al.  Genome Sequence of Aedes aegypti, a Major Arbovirus Vector , 2007, Science.

[274]  J. Sejvar.  The long-term outcomes of human West Nile virus infection. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[275]  Y. Huang,et al.  A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity. , 2007, The Journal of infectious diseases.

[276]  M. Diamond,et al.  The molecular basis of antibody-mediated neutralization of West Nile virus , 2007, Expert opinion on biological therapy.

[277]  P. Halbur,et al.  West Nile Virus Viremia in Eastern Chipmunks (Tamias striatus) Sufficient for Infecting Different Mosquitoes , 2007, Emerging infectious diseases.

[278]  Christine L Miller,et al.  ANTIBODY RESPONSE OF FIVE BIRD SPECIES AFTER VACCINATION WITH A KILLED WEST NILE VIRUS VACCINE , 2007, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.

[279]  Alex Y Strongin,et al.  Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold , 2007, Protein science : a publication of the Protein Society.

[280]  K. Padgett,et al.  West Nile virus infection in tree squirrels (Rodentia: Sciuridae) in California, 2004-2005. , 2007, The American journal of tropical medicine and hygiene.

[281]  C. J. Bennett,et al.  A mouse cell-adapted NS4B mutation attenuates West Nile virus RNA synthesis. , 2007, Virology.

[282]  M. Diamond,et al.  Defining Limits of Treatment with Humanized Neutralizing Monoclonal Antibody for West Nile Virus Neurological Infection in a Hamster Model , 2007, Antimicrobial Agents and Chemotherapy.

[283]  A. Baier,et al.  An analogue of AICAR with dual inhibitory activity against WNV and HCV NTPase/helicase: synthesis and in vitro screening of 4-carbamoyl-5-(4,6-diamino-2,5-dihydro-1,3,5-triazin-2-yl)imidazole-1-beta-D-ribofuranoside. , 2007, Bioorganic & medicinal chemistry letters.

[284]  M. Siirin,et al.  Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis. , 2007, Vaccine.

[285]  D. Bicout,et al.  Bird species potentially involved in introduction, amplification, and spread of West Nile virus in a Mediterranean wetland, the Camargue (Southern France). , 2007, Vector borne and zoonotic diseases.

[286]  N. Osterrieder,et al.  Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV). , 2007, Virus research.

[287]  M. Rossmann,et al.  Structure of Immature West Nile Virus , 2007, Journal of Virology.

[288]  C. Kotton,et al.  Zoonoses in solid-organ and hematopoietic stem cell transplant recipients. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[289]  A. Glaser,et al.  Clinical Findings, Lesions, and Viral Antigen Distribution in Great Gray Owls (Strix nebulosa) and Barred Owls (Strix varia) with Spontaneous West Nile Virus Infection , 2007, Avian diseases.

[290]  Wei Liu,et al.  A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. , 2007, The Journal of infectious diseases.

[291]  Daniel R. O’Leary,et al.  Transmission of West Nile Virus Through Human Breast Milk Seems to Be Rare , 2007, Pediatrics.

[292]  V. Arankalle,et al.  West Nile virus isolates from India: evidence for a distinct genetic lineage. , 2007, The Journal of general virology.

[293]  A. Brault,et al.  Ability of Transstadially Infected Ixodes pacificus (Acari: Ixodidae) to Transmit West Nile Virus to Song Sparrows or Western Fence Lizards , 2007, Journal of medical entomology.

[294]  Subhash G. Vasudevan,et al.  Crystal Structure of the Dengue Virus RNA-Dependent RNA Polymerase Catalytic Domain at 1.85-Angstrom Resolution , 2007, Journal of Virology.

[295]  J. Balzarini.  Carbohydrate-Binding Agents: A Potential Future Cornerstone for the Chemotherapy of Enveloped Viruses? , 2007, Antiviral chemistry & chemotherapy.

[296]  Susan A. Jones,et al.  Cell-specific adaptation of two flaviviruses following serial passage in mosquito cell culture. , 2007, Virology.

[297]  M. Siirin,et al.  Preparation and immunogenic properties of a recombinant West Nile subunit vaccine. , 2007, Vaccine.

[298]  Ashish,et al.  Antiviral Peptides Targeting the West Nile Virus Envelope Protein , 2006, Journal of Virology.

[299]  M. Gao,et al.  A homogeneous, solid-phase assay for hepatitis C virus RNA-dependent RNA polymerase. , 2006, Analytical biochemistry.

[300]  J. Chu,et al.  Expression of vector-based small interfering RNA against West Nile virus effectively inhibits virus replication. , 2006, Antiviral research.

[301]  C. Huang,et al.  Avian virulence and thermostable replication of the North American strain of West Nile virus. , 2006, The Journal of general virology.

[302]  John F Anderson,et al.  Importance of vertical and horizontal transmission of West Nile virus by Culex pipiens in the Northeastern United States. , 2006, The Journal of infectious diseases.

[303]  S. Pergam,et al.  Myocarditis in West Nile Virus infection. , 2006, The American journal of tropical medicine and hygiene.

[304]  K. Yoon,et al.  Monoclonal Antibody-Based Competitive Enzyme-Linked Immunosorbent Assay for Detecting and Quantifying West Nile Virus-Neutralizing Antibodies in Horse Sera , 2006, Clinical and Vaccine Immunology.

[305]  S. Vasudevan,et al.  Peptide inhibitors of West Nile NS3 protease: SAR study of tetrapeptide aldehyde inhibitors. , 2006, Journal of medicinal chemistry.

[306]  M. Diamond,et al.  Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters. , 2006, The Journal of infectious diseases.

[307]  P. Gallian,et al.  Inactivation of a European strain of West Nile virus in single‐ donor platelet concentrate using the INTERCEPT blood system , 2006, Vox sanguinis.

[308]  C. Waldner,et al.  Prediction of human cases of West Nile virus by equine cases, Saskatchewan, Canada, 2003. , 2006, Preventive veterinary medicine.

[309]  M. Diamond,et al.  Pathogenesis of West Nile Virus Infection: a Balance between Virulence, Innate and Adaptive Immunity, and Viral Evasion , 2006, Journal of Virology.

[310]  R. Bowen,et al.  West Nile virus quantification in feces of experimentally infected American and fish crows. , 2006, The American journal of tropical medicine and hygiene.

[311]  H. Zeller,et al.  First International Proficiency Study on West Nile Virus Molecular Detection , 2006, Clinical chemistry.

[312]  B. Murphy,et al.  Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity. , 2006, Vaccine.

[313]  P. Daszak,et al.  Host heterogeneity dominates West Nile virus transmission , 2006, Proceedings of the Royal Society B: Biological Sciences.

[314]  D. Stallknecht,et al.  Antibodies to West Nile virus in feral swine from Florida, Georgia, and Texas, USA. , 2006, Vector borne and zoonotic diseases.

[315]  Ross D Crosby,et al.  Long-term clinical and neuropsychological outcomes of West Nile virus infection. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[316]  K. Christensen,et al.  Field-Caught Culex erythrothorax Larvae Found Naturally Infected with West Nile Virus in Grand County, Utah , 2006, Journal of the American Mosquito Control Association.

[317]  R. DeBiasi,et al.  West Nile virus neuroinvasive disease , 2006, Annals of neurology.

[318]  Y. Modis,et al.  Crystal Structure of West Nile Virus Envelope Glycoprotein Reveals Viral Surface Epitopes , 2006, Journal of Virology.

[319]  P. Desprès,et al.  Comparative mechanistic studies of de novo RNA synthesis by flavivirus RNA-dependent RNA polymerases. , 2006, Virology.

[320]  J. Sejvar,et al.  Manifestations of West Nile neuroinvasive disease , 2006, Reviews in medical virology.

[321]  R. Koski,et al.  Detection of Antibodies to West Nile Virus in Equine Sera Using Microsphere Immunoassay , 2006, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[322]  R. DeBiasi,et al.  West Nile virus meningoencephalitis , 2006, Nature Clinical Practice Neurology.

[323]  J. Sejvar,et al.  West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[324]  S. Green,et al.  A live, attenuated recombinant West Nile virus vaccine. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[325]  Jeremy Johnson,et al.  Pathogenesis of West Nile virus infection in dogs treated with glucocorticoids. , 2006, The American journal of tropical medicine and hygiene.

[326]  E. Ferenczi,et al.  Lineage 1 and 2 Strains of Encephalitic West Nile Virus, Central Europe , 2006, Emerging infectious diseases.

[327]  S. Kleinman,et al.  The development of West Nile virus safety policies by Canadian blood services: guiding principles and a comparison between Canada and the United States. , 2006, Transfusion medicine reviews.

[328]  P. Shi,et al.  West Nile virus infection of the placenta. , 2006, Virology.

[329]  E. Hayes,et al.  Cost-effectiveness of West Nile Virus Vaccination , 2006, Emerging infectious diseases.

[330]  A. Kwong,et al.  Preclinical Profile of VX-950, a Potent, Selective, and Orally Bioavailable Inhibitor of Hepatitis C Virus NS3-4A Serine Protease , 2006, Antimicrobial Agents and Chemotherapy.

[331]  P. Desprès,et al.  A single immunization with a minute dose of a lentiviral vector‐based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus , 2006, The journal of gene medicine.

[332]  W. Reisen,et al.  Effects of Temperature on the Transmission of West Nile Virus by Culex tarsalis (Diptera: Culicidae) , 2006, Journal of medical entomology.

[333]  John F Anderson,et al.  Host Feeding Patterns of Culex Mosquitoes and West Nile Virus Transmission, Northeastern United States , 2006, Emerging infectious diseases.

[334]  Daniel R. O’Leary,et al.  Birth Outcomes Following West Nile Virus Infection of Pregnant Women in the United States: 2003-2004 , 2006, Pediatrics.

[335]  J. Sejvar,et al.  Persistent neuroinvasive West Nile virus infection in an immunocompromised patient. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[336]  Brian D. Carroll,et al.  Role of Corvids in Epidemiology of West Nile Virus in Southern California , 2006, Journal of medical entomology.

[337]  A. Kwong,et al.  Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3.4A serine protease. , 2006, Infectious disorders drug targets.

[338]  Priti Kumar,et al.  A Single siRNA Suppresses Fatal Encephalitis Induced by Two Different Flaviviruses , 2006, PLoS medicine.

[339]  D. McDermott,et al.  CCR5 deficiency increases risk of symptomatic West Nile virus infection , 2006, The Journal of experimental medicine.

[340]  Millicent Eidson,et al.  Geographic prediction of human onset of West Nile virus using dead crow clusters: an evaluation of year 2002 data in New York State. , 2006, American journal of epidemiology.

[341]  D. Gubler,et al.  West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. , 2006, Annual review of medicine.

[342]  M. Diamond,et al.  CD8+ T Cells Require Perforin To Clear West Nile Virus from Infected Neurons , 2006, Journal of Virology.

[343]  M. Busch,et al.  Immunoglobulin G Avidity in Differentiation between Early and Late Antibody Responses to West Nile Virus , 2006, Clinical and Vaccine Immunology.

[344]  P. Bochsler,et al.  Evaluation of Antigen-Capture ELISA and Immunohistochemical Methods for Avian Surveillance of West Nile Virus , 2006, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[345]  T. Oliphant,et al.  Protective and Therapeutic Capacity of Human Single-Chain Fv-Fc Fusion Proteins against West Nile Virus , 2005, Journal of Virology.

[346]  Yasuaki Shimizu,et al.  High-Throughput Screening of Low Molecular Weight NS3-NS4A Protease Inhibitors Using a Fluorescence Resonance Energy Transfer Substrate , 2005, Antiviral chemistry & chemotherapy.

[347]  Jeffrey S. Hall,et al.  West Nile virus serosurveillance in Iowa white-tailed deer (1999-2003). , 2005, The American journal of tropical medicine and hygiene.

[348]  M. Drebot,et al.  Use of Immunoglobulin G Avidity Assays for Differentiation of Primary from Previous Infections with West Nile Virus , 2005, Journal of Clinical Microbiology.

[349]  R. Tesh,et al.  NS1 Protein Secretion during the Acute Phase of West Nile Virus Infection , 2005, Journal of Virology.

[350]  D. Smee,et al.  Broad-spectrum inhibitor of viruses in the Flaviviridae family. , 2005, Antiviral research.

[351]  M. Diamond,et al.  Alpha/Beta Interferon Protects against Lethal West Nile Virus Infection by Restricting Cellular Tropism and Enhancing Neuronal Survival , 2005, Journal of Virology.

[352]  E. Miska,et al.  MicroRNA functions in animal development and human disease , 2005, Development.

[353]  L. Kramer,et al.  Assays to Detect West Nile Virus in Dead Birds , 2005, Emerging infectious diseases.

[354]  R. Cholera,et al.  Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection , 2005, The Journal of experimental medicine.

[355]  L. Petersen,et al.  Characteristics of the rash associated with West Nile virus fever. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[356]  A. Kwong,et al.  Viral and cellular RNA helicases as antiviral targets , 2005, Nature Reviews Drug Discovery.

[357]  P. Sarnow,et al.  Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.

[358]  L. Kramer,et al.  Dead Crow Density and West Nile Virus Monitoring, New York , 2005, Emerging infectious diseases.

[359]  E. De Clercq.  Recent highlights in the development of new antiviral drugs , 2005, Current Opinion in Microbiology.

[360]  Peter Tomasulo,et al.  Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. , 2005, The New England journal of medicine.

[361]  G. Foster,et al.  West Nile virus among blood donors in the United States, 2003 and 2004. , 2005, The New England journal of medicine.

[362]  Daniel R. O’Leary,et al.  Epidemiology and Transmission Dynamics of West Nile Virus Disease , 2005, Emerging infectious diseases.

[363]  J. Sejvar,et al.  Virology, Pathology, and Clinical Manifestations of West Nile Virus Disease , 2005, Emerging infectious diseases.

[364]  T. Pierson,et al.  Actively replicating West Nile virus is resistant to cytoplasmic delivery of siRNA , 2005, Virology Journal.

[365]  C. Huang,et al.  Chimeric Dengue 2 PDK-53/West Nile NY99 Viruses Retain the Phenotypic Attenuation Markers of the Candidate PDK-53 Vaccine Virus and Protect Mice against Lethal Challenge with West Nile Virus , 2005, Journal of Virology.

[366]  R. Koski,et al.  A recombinant envelope protein vaccine against West Nile virus. , 2005, Vaccine.

[367]  Scott F Michael,et al.  Peptide inhibitors of dengue virus and West Nile virus infectivity , 2005, Virology Journal.

[368]  S. Higgs,et al.  Ultrastructural Study of West Nile Virus Pathogenesis in Culex pipiens quinquefasciatus (Diptera: Culicidae) , 2005, Journal of medical entomology.

[369]  Jeffrey S. Hall,et al.  Serologic evidence of exposure of wild mammals to flaviviruses in the central and eastern United States. , 2005, The American journal of tropical medicine and hygiene.

[370]  W. Reisen,et al.  Avian Host and Mosquito (Diptera: Culicidae) Vector Competence Determine the Efficiency of West Nile and St. Louis Encephalitis Virus Transmission , 2005, Journal of medical entomology.

[371]  Chris Doane,et al.  Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus , 2005, Nature Medicine.

[372]  A. Saïb,et al.  A Cellular MicroRNA Mediates Antiviral Defense in Human Cells , 2005, Science.

[373]  C. Banet-Noach,et al.  Argasid ticks as possible vectors of West Nile virus in Israel. , 2005, Vector borne and zoonotic diseases.

[374]  E. Fikrig,et al.  Use of RNA interference to prevent lethal murine west nile virus infection. , 2005, The Journal of infectious diseases.

[375]  J. Saldanha,et al.  West Nile virus in Canadian blood donors , 2005, Transfusion.

[376]  W. Reeves,et al.  Antibody response to Culex tarsalis salivary gland antigens among sentinel chickens in California. , 2005, The American journal of tropical medicine and hygiene.

[377]  R. Lanciotti,et al.  Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic , 2005, Transfusion.

[378]  Richard S Larson,et al.  Design and structure of peptide and peptidomimetic antagonists of protein-protein interaction. , 2005, Current protein & peptide science.

[379]  L. Corash,et al.  Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long‐wavelength ultraviolet light , 2005, Transfusion.

[380]  M. Siirin,et al.  Persistent shedding of West Nile virus in urine of experimentally infected hamsters. , 2005, The American journal of tropical medicine and hygiene.

[381]  R. Tesh,et al.  Oral transmission of West Nile virus in a hamster model. , 2005, The American journal of tropical medicine and hygiene.

[382]  D. Rodríguez,et al.  West Nile Virus Encephalitis in a Dog , 2005, Veterinary pathology.

[383]  T. Chambers,et al.  Neuroblastoma cell-adapted yellow fever virus: mutagenesis of the E protein locus involved in persistent infection and its effects on virus penetration and spread. , 2005, The Journal of general virology.

[384]  E. De Clercq,et al.  The Predominant Mechanism by Which Ribavirin Exerts Its Antiviral Activity In Vitro against Flaviviruses and Paramyxoviruses Is Mediated by Inhibition of IMP Dehydrogenase , 2005, Journal of Virology.

[385]  Z. Hubálek,et al.  Novel Flavivirus or New Lineage of West Nile Virus, Central Europe , 2005, Emerging infectious diseases.

[386]  P. Desprès,et al.  Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis. , 2005, The Journal of infectious diseases.

[387]  N. Waugh,et al.  Clinical- and cost-effectiveness of pegylated interferon alfa in the treatment of chronic hepatitis C: A systematic review and economic evaluation , 2005, International Journal of Technology Assessment in Health Care.

[388]  N. Cohen,et al.  Evaluation of administration of West Nile virus vaccine to pregnant broodmares. , 2004, Journal of the American Veterinary Medical Association.

[389]  C. W. Kwok,et al.  An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development. , 2004, Virology.

[390]  L. Kramer,et al.  VecTest as Diagnostic and Surveillance Tool for West Nile Virus in Dead Birds , 2004, Emerging infectious diseases.

[391]  A. Brault,et al.  Differential Virulence of West Nile Strains for American Crows , 2004, Emerging infectious diseases.

[392]  D. Gubler,et al.  Alligators as West Nile Virus Amplifiers , 2004, Emerging infectious diseases.

[393]  K. Karaca,et al.  Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses. , 2004, American journal of veterinary research.

[394]  M. Ng,et al.  Infectious Entry of West Nile Virus Occurs through a Clathrin-Mediated Endocytic Pathway , 2004, Journal of Virology.

[395]  C. Caruso,et al.  Impairment of gamma/delta T lymphocytes in elderly: implications for immunosenescence , 2004, Experimental Gerontology.

[396]  Giovanni Migliaccio,et al.  A 7-Deaza-Adenosine Analog Is a Potent and Selective Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic Properties , 2004, Antimicrobial Agents and Chemotherapy.

[397]  T. Tuschl,et al.  Mechanisms of gene silencing by double-stranded RNA , 2004, Nature.

[398]  Roderick C. Jones,et al.  Clinical Characteristics and Functional Outcomes of West Nile Fever , 2004, Annals of Internal Medicine.

[399]  Jean-Louis Romette,et al.  A Structural Basis for the Inhibition of the NS5 Dengue Virus mRNA 2′-O-Methyltransferase Domain by Ribavirin 5′-Triphosphate* , 2004, Journal of Biological Chemistry.

[400]  K. Tyler,et al.  Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. , 2004, Archives of neurology.

[401]  J. Traub-Dargatz,et al.  Outcome of equids with clinical signs of West Nile virus infection and factors associated with death. , 2004, Journal of the American Veterinary Medical Association.

[402]  Daniel R. O’Leary,et al.  The epidemic of West Nile virus in the United States, 2002. , 2004, Vector borne and zoonotic diseases.

[403]  H. Weingartl,et al.  Experimental West Nile Virus Infection in Blue Jays (Cyanocitta cristata) and Crows (Corvus brachyrhynchos) , 2004, Veterinary pathology.

[404]  James Wood,et al.  West Nile virus infection of horses. , 2004, Veterinary research.

[405]  L. Strokovskaya,et al.  Direct fluorometric measurement of hepatitis C virus helicase activity , 2004, FEBS letters.

[406]  M. Root,et al.  HIV-1 gp41 as a target for viral entry inhibition. , 2004, Current pharmaceutical design.

[407]  Jennifer J. D'Agostino,et al.  Clinical signs and results of specific diagnostic testing among captive birds housed at zoological institutions and infected with West Nile virus. , 2004, Journal of the American Veterinary Medical Association.

[408]  E. Saito,et al.  Corvidae Feather Pulp and West Nile Virus Detection , 2004, Emerging infectious diseases.

[409]  Daniel R. O’Leary,et al.  West Nile virus infection: a pediatric perspective. , 2004, Pediatrics.

[410]  Roderick C. Jones,et al.  Dead Crow Reports and Location of Human West Nile Virus Cases, Chicago, 2002 , 2004, Emerging infectious diseases.

[411]  L. S. Risley,et al.  West Nile Virus Antibodies in Bats from New Jersey and New York , 2004, Journal of wildlife diseases.

[412]  D. Smee,et al.  Effect of Interferon-Alpha and Interferon-Inducers on West Nile Virus in Mouse and Hamster Animal Models , 2004, Antiviral chemistry & chemotherapy.

[413]  Carol Beth Post,et al.  Solution structure of dengue virus capsid protein reveals another fold. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[414]  Thomas Tuschl,et al.  Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. , 2004, RNA.

[415]  K. Stiasny,et al.  Structure of a flavivirus envelope glycoprotein in its low‐pH‐induced membrane fusion conformation , 2004, The EMBO journal.

[416]  B. Malcolm,et al.  A continuous nonradioactive assay for RNA-dependent RNA polymerase activity. , 2004, Analytical biochemistry.

[417]  Deepali Kumar,et al.  Community-acquired West Nile virus infection in solid-organ transplant recipients , 2004, Transplantation.

[418]  C. Mandl,et al.  Mimicking live flavivirus immunization with a noninfectious RNA vaccine , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[419]  S. Behrens,et al.  Synthesis and Evaluation of ATP-Binding Site Directed Potential Inhibitors of Nucleoside Triphosphatases/ Helicases and Polymerases of Hepatitis C and other Selected Flaviviridae Viruses , 2004, Antiviral chemistry & chemotherapy.

[420]  B. Kelley,et al.  West Nile Virus inactivation by the solvent/detergent steps of the second and third generation manufacturing processes for B‐domain deleted recombinant factor VIII , 2004, Haemophilia : the official journal of the World Federation of Hemophilia.

[421]  G. Chang,et al.  Experimental Infection of Cats and Dogs with West Nile Virus , 2004, Emerging infectious diseases.

[422]  G. Johnson,et al.  Diagnosis of West Nile Virus Infection in Horses , 2004, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[423]  M. Diamond,et al.  Antibody Prophylaxis and Therapy against West NileVirus Infection in Wild-Type and ImmunodeficientMice , 2003, Journal of Virology.

[424]  T. Scott,et al.  Vertical Transmission of West Nile Virus by Three California Culex (Diptera: Culicidae) Species , 2003, Journal of medical entomology.

[425]  Bong-Suk Kim,et al.  Structure of West Nile Virus , 2003, Science.

[426]  M. Minczuk,et al.  Potent inhibition of NTPase/helicase of the West Nile Virus by ring-expanded ("fat") nucleoside analogues. , 2003, Journal of medicinal chemistry.

[427]  M. Haley,et al.  The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[428]  R. Chanock,et al.  Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus. , 2003, Virology.

[429]  M. Diamond,et al.  The utility of siRNA transcripts produced by RNA polymerase i in down regulating viral gene expression and replication of negative- and positive-strand RNA viruses. , 2003, Virology.

[430]  A. Fattom,et al.  Ring-expanded ("fat") nucleoside and nucleotide analogues exhibit potent in vitro activity against flaviviridae NTPases/helicases, including those of the West Nile virus, hepatitis C virus, and Japanese encephalitis virus. , 2003, Journal of medicinal chemistry.

[431]  D. J. Nisbet,et al.  DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[432]  J. Kindermann,et al.  West Nile virus and the safety of plasma derivatives: verification of high safety margins, and the validity of predictions based on model virus data , 2003, Transfusion.

[433]  Susan A. Jones,et al.  Virus Detection Protocols for West Nile Virus in Vertebrate and Mosquito Specimens , 2003, Journal of Clinical Microbiology.

[434]  R. Tesh,et al.  West Nile virus in blood: stability, distribution, and susceptibility to PEN110 inactivation , 2003, Transfusion.

[435]  D. Gubler,et al.  Serologic Evidence of West Nile Virus Infection in Horses, Coahuila State, Mexico , 2003, Emerging infectious diseases.

[436]  J. Sejvar,et al.  Acute Flaccid Paralysis and West Nile Virus Infection , 2003, Emerging infectious diseases.

[437]  R. Lanciotti,et al.  Transmission of West Nile virus from an organ donor to four transplant recipients. , 2003, The New England journal of medicine.

[438]  C. Cheng‐Mayer,et al.  Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[439]  Y. Modis,et al.  A ligand-binding pocket in the dengue virus envelope glycoprotein , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[440]  Alison Johnson,et al.  Detection of Anti-West Nile Virus Immunoglobulin M in Chicken Serum by an Enzyme-Linked Immunosorbent Assay , 2003, Journal of Clinical Microbiology.

[441]  Kotaro Yasui,et al.  Inoculation of Plasmids Encoding Japanese Encephalitis Virus PrM-E Proteins with Colloidal Gold Elicits a Protective Immune Response in BALB/c Mice , 2003, Journal of Virology.

[442]  W. Patrick Walters,et al.  A guide to drug discovery: Designing screens: how to make your hits a hit , 2003, Nature Reviews Drug Discovery.

[443]  Sarah Schalinski,et al.  Halogenated benzimidazoles and benzotriazoles as inhibitors of the NTPase/helicase activities of hepatitis C and related viruses. , 2003, European journal of biochemistry.

[444]  Denise A. Martin,et al.  Persistence of Virus-Reactive Serum Immunoglobulin M Antibody in Confirmed West Nile Virus Encephalitis Cases , 2003, Emerging infectious diseases.

[445]  R. Bowen,et al.  Experimental Infection of North American Birds with the New York 1999 Strain of West Nile Virus , 2003, Emerging infectious diseases.

[446]  Y. Berdichevsky,et al.  A novel high throughput screening assay for HCV NS3 serine protease inhibitors. , 2003, Journal of virological methods.

[447]  M. Diamond,et al.  Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA. , 2002, Virology.

[448]  N. Kedersha,et al.  Cell Proteins TIA-1 and TIAR Interact with the 3′ Stem-Loop of the West Nile Virus Complementary Minus-Strand RNA and Facilitate Virus Replication , 2002, Journal of Virology.

[449]  R. Rappuoli,et al.  Reverse vaccinology: a genome-based approach for vaccine development , 2002, Expert opinion on biological therapy.

[450]  Armando Giovannini,et al.  West Nile virus Epidemic in Horses, Tuscany Region, Italy , 2002, Emerging infectious diseases.

[451]  J. P. Montgomery,et al.  Possible West Nile virus transmission to an infant through breast-feeding--Michigan, 2002. , 2002, MMWR. Morbidity and mortality weekly report.

[452]  William K. Reisen,et al.  Vector Competence of California Mosquitoes for West Nile virus , 2002, Emerging infectious diseases.

[453]  Y. Berner,et al.  Outcome of West Nile Fever in Older Adults , 2002, Journal of the American Geriatrics Society.

[454]  D. Stokic,et al.  A poliomyelitis-like syndrome from West Nile virus infection. , 2002, The New England journal of medicine.

[455]  M. Rich,et al.  Poliomyelitis due to West Nile virus. , 2002, The New England journal of medicine.

[456]  S. Pitlik,et al.  Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis , 2002, Transplant infectious disease : an official journal of the Transplantation Society.

[457]  C. Samuel,et al.  Host genetic variability and West Nile virus susceptibility , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[458]  L. Petersen,et al.  West Nile Virus: A Primer for the Clinician , 2002, Annals of Internal Medicine.

[459]  D. Mayo,et al.  Inactivation of West Nile Virus during Serologic Testing and Transport , 2002, Journal of Clinical Microbiology.

[460]  R. Swanepoel,et al.  Phylogenetic Relationships of Southern African West Nile Virus Isolates , 2002, Emerging infectious diseases.

[461]  R. Cook,et al.  An outbreak of West Nile virus in a New York City captive wildlife population. , 2002, The American journal of tropical medicine and hygiene.

[462]  A. Url,et al.  Emergence of Usutu virus, an African Mosquito-Borne Flavivirus of the Japanese Encephalitis Virus Group, Central Europe , 2002, Emerging infectious diseases.

[463]  E. Mariani,et al.  Chemokine production by natural killer cells from nonagenarians , 2002, European journal of immunology.

[464]  J. Choe,et al.  Characterization of Imidazo[4,5-d]Pyridazine Nucleosides as Modulators of Unwinding Reaction Mediated by West Nile Virus Nucleoside Triphosphatase/Helicase: Evidence for Activity on the Level of Substrate and/or Enzyme , 2002, Antimicrobial Agents and Chemotherapy.

[465]  V. Deubel,et al.  Introduction of West Nile Virus in the Middle East by Migrating White Storks , 2002, Emerging infectious diseases.

[466]  J. Shield,et al.  Type 2 diabetes in obese white children , 2002, Archives of disease in childhood.

[467]  C. Caruso,et al.  Gamma/delta T lymphocytes are affected in the elderly , 2002, Experimental Gerontology.

[468]  M. Stanford,et al.  The neurobehavioural consequences of St. Louis encephalitis infection , 2002, Brain injury.

[469]  Martin J. Stoermer,et al.  Activity of Recombinant Dengue 2 Virus NS3 Protease in the Presence of a Truncated NS2B Co-factor, Small Peptide Substrates, and Inhibitors* , 2001, The Journal of Biological Chemistry.

[470]  M. Brinton.  Host Factors Involved in West Nile Virus Replication , 2001, Annals of the New York Academy of Sciences.

[471]  T. Monath.  Prospects for Development of a Vaccine against the West Nile Virus , 2001, Annals of the New York Academy of Sciences.

[472]  V. Deubel,et al.  West Nile in the Mediterranean Basin: 1950‐2000 , 2001, Annals of the New York Academy of Sciences.

[473]  A. Platonov.  West Nile Encephalitis in Russia 1999‐2001 , 2001, Annals of the New York Academy of Sciences.

[474]  E. Mendelson,et al.  West Nile Fever in Israel 1999‐2000 , 2001, Annals of the New York Academy of Sciences.

[475]  N. Komar.  West Nile Virus Surveillance using Sentinel Birds , 2001, Annals of the New York Academy of Sciences.

[476]  D. Vaughn,et al.  Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region. , 2001, The American journal of tropical medicine and hygiene.

[477]  L. Kramer,et al.  West Nile virus in the western hemisphere , 2001, Current opinion in infectious diseases.

[478]  T. Monath,et al.  Yellow fever vector live-virus vaccines: West Nile virus vaccine development , 2001, Trends in Molecular Medicine.

[479]  R. Lanciotti,et al.  West Nile virus outbreak among horses in New York State, 1999 and 2000. , 2001, Emerging infectious diseases.

[480]  S. Langevin,et al.  Experimental infection of chickens as candidate sentinels for West Nile virus. , 2001, Emerging infectious diseases.

[481]  K. Schmit,et al.  Dead bird surveillance as an early warning system for West Nile virus. , 2001, Emerging infectious diseases.

[482]  S. Pitlik,et al.  Clinical characteristics of the West Nile fever outbreak, Israel, 2000. , 2001, Emerging infectious diseases.

[483]  Z. Hubálek.  Comparative symptomatology of West Nile fever , 2001, The Lancet.

[484]  Farzad Mostashari,et al.  Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey , 2001, The Lancet.

[485]  S. Bulvik,et al.  Treatment of West Nile virus encephalitis with intravenous immunoglobulin. , 2001, Emerging infectious diseases.

[486]  N. Komar,et al.  Exposure of domestic mammals to West Nile virus during an outbreak of human encephalitis, New York City, 1999. , 2001, Emerging infectious diseases.

[487]  F. Mostashari,et al.  Crow deaths as a sentinel surveillance system for West Nile virus in the northeastern United States, 1999. , 2001, Emerging infectious diseases.

[488]  S. Robinson.  National diet and nutrition survey: young people aged 4 to 18 years , 2001 .

[489]  Daniel R. O’Leary,et al.  The outbreak of West Nile virus infection in the New York City area in 1999. , 2001, The New England journal of medicine.

[490]  H. Schmitz,et al.  Purification and Characterization of West Nile Virus Nucleoside Triphosphatase (NTPase)/Helicase: Evidence for Dissociation of the NTPase and Helicase Activities of the Enzyme , 2001, Journal of Virology.

[491]  A. Astrup,et al.  Obesity : Preventing and managing the global epidemic , 2000 .

[492]  T. Briese,et al.  Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells. , 2000, The Journal of infectious diseases.

[493]  S. Pavlakis,et al.  Rhombencephalitis caused by West Nile fever virus , 2000, Neurology.

[494]  R. Libman,et al.  Guillain–Barré syndrome: An unusual presentation of West Nile virus infection , 2000, Neurology.

[495]  R. Lanciotti,et al.  Pathology of Fatal West Nile Virus Infections in Native and Exotic Birds during the 1999 Outbreak in New York City, New York , 2000, Veterinary pathology.

[496]  M. Turell,et al.  Potential for New York mosquitoes to transmit West Nile virus. , 2000, The American journal of tropical medicine and hygiene.

[497]  D. K. L’vov.  [West Nile fever]. , 2000, Voprosy virusologii.

[498]  D. Asnis,et al.  The West Nile Virus outbreak of 1999 in New York: the Flushing Hospital experience. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[499]  R. Lanciotti,et al.  First field evidence for natural vertical transmission of West Nile virus in Culex univittatus complex mosquitoes from Rift Valley province, Kenya. , 2000, The American journal of tropical medicine and hygiene.

[500]  S. Warschausky,et al.  Principles of Neuropsychological Rehabilitation , 1999 .

[501]  A. Fire,et al.  RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[502]  W. Reisen,et al.  A new enzyme immunoassay to detect antibodies to arboviruses in the blood of wild birds. , 1998, Journal of vector ecology : journal of the Society for Vector Ecology.

[503]  A. Patick,et al.  Protease Inhibitors as Antiviral Agents , 1998, Clinical Microbiology Reviews.

[504]  C Cernescu,et al.  West Nile encephalitis epidemic in southeastern Romania , 1998, The Lancet.

[505]  E. G. Westaway,et al.  Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A. , 1998, Virology.

[506]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[507]  K. Shimotohno,et al.  Non‐peptide inhibitors of HCV serine proteinase , 1998, FEBS letters.

[508]  D. Pfarr,et al.  Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. , 1997, The Journal of infectious diseases.

[509]  F. Heinz,et al.  Proteolytic activation of tick-borne encephalitis virus by furin , 1997, Journal of virology.

[510]  M. Eibl,et al.  Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model , 1997, Journal of virology.

[511]  G. Prince,et al.  Immunoprophylaxis of group B respiratory syncytial virus infection in cotton rats. , 1997, The Journal of infectious diseases.

[512]  W. Li,et al.  Cell proteins bind specifically to West Nile virus minus-strand 3' stem-loop RNA , 1996, Journal of virology.

[513]  K. Shimotohno,et al.  Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography. , 1996, Antiviral research.

[514]  S. Carding,et al.  Gamma/delta T lymphocytes in viral Infections , 1995, Journal of leukocyte biology.

[515]  M. Brinton,et al.  BHK cell proteins that bind to the 3' stem-loop structure of the West Nile virus genome RNA , 1995, Journal of virology.

[516]  B. Gay,et al.  Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles , 1995, Journal of virology.

[517]  L. Donaldson.  Doctors with problems in an NHS workforce , 1994, BMJ.

[518]  J. Murphy,et al.  Vertical transmission of West Nile virus by Culex and Aedes species mosquitoes. , 1993, The American journal of tropical medicine and hygiene.

[519]  A. Cornel,et al.  Environmental temperature on the vector competence of Culex univittatus (Diptera: Culicidae) for West Nile virus. , 1993, Journal of medical entomology.

[520]  C. Lai,et al.  Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins , 1991, Journal of virology.

[521]  W. London.  Gamma/delta T-cell receptors , 1991, The Lancet.

[522]  L. Rosen,et al.  Overwintering mechanisms of mosquito-borne arboviruses in temperate climates. , 1987, The American journal of tropical medicine and hygiene.

[523]  M. M. Milby,et al.  Air conditioning and television as protective factors in arboviral encephalitis risk. , 1986, The American journal of tropical medicine and hygiene.

[524]  Y. Nir,et al.  Isolation of West Nile virus strains from mosquitoes in Israel. , 1968, American journal of epidemiology.

[525]  T. P. Hughes,et al.  A neurotropic virus isolated from the blood of a native of Uganda , 1940 .

[526]  D. Gubler,et al.  Dengue and dengue hemorrhagic fever. , 2014 .

[527]  Xuping Xie,et al.  U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication. , 2012, Antiviral research.

[528]  T. Davies,et al.  Fragment screening using X-ray crystallography. , 2012, Topics in current chemistry.

[529]  Alicia M. Hanson,et al.  Identification and analysis of inhibitors targeting the hepatitis C virus NS3 helicase. , 2012, Methods in enzymology.

[530]  N. Becker,et al.  Ochlerotatus japonicus japonicus - a newly established neozoan in Germany and a revised list of the German mosquito fauna , 2011 .

[531]  M. Watson,et al.  Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults. , 2011, The Journal of infectious diseases.

[532]  A. Brault,et al.  differential replicative capacity in response to temperature , 2011 .

[533]  S. Bonovas,et al.  Ongoing outbreak of West Nile virus infection in humans, Greece, July to August 2011. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[534]  E. Decroly,et al.  Biochemical characterization of the (nucleoside-2'O)-methyltransferase activity of dengue virus protein NS5 using purified capped RNA oligonucleotides (7Me)GpppAC(n) and GpppAC(n). , 2010, The Journal of general virology.

[535]  M. Saad,et al.  Studies on West Nile virus infection in Egypt. , 2010, Journal of infection and public health.

[536]  Jessica A. Lewis,et al.  Persistent infection with West Nile virus years after initial infection. , 2010, The Journal of infectious diseases.

[537]  J. Smit,et al.  Short Communication Characterization of the functional requirements of West Nile virus membrane fusion , 2010 .

[538]  A. Davidson.  Chapter 2. New insights into flavivirus nonstructural protein 5. , 2009, Advances in virus research.

[539]  M. Walid,et al.  Successful treatment with intravenous immunoglobulin of acute flaccid paralysis caused by west nile virus. , 2009, The Permanente journal.

[540]  K. Ellingson,et al.  West Nile virus transmission via organ transplantation and blood transfusion - Louisiana, 2008. , 2009, MMWR. Morbidity and mortality weekly report.

[541]  J. Modrof,et al.  West Nile virus infection in plasma of blood and plasma donors, United States. , 2009, Emerging infectious diseases.

[542]  E. Gould,et al.  Pathogenic fl aviviruses , 2008 .

[543]  S. Halstead,et al.  Dengue virus-mosquito interactions. , 2008, Annual review of entomology.

[544]  R. Padmanabhan,et al.  Characterization of the West Nile virus protease substrate specificity and inhibitors. , 2007, The international journal of biochemistry & cell biology.

[545]  West Nile virus update--United States, January 1--august 14, 2007. , 2007, MMWR. Morbidity and mortality weekly report.

[546]  West Nile virus transmission through blood transfusion--South Dakota, 2006. , 2007, MMWR. Morbidity and mortality weekly report.

[547]  Christopher N Mores,et al.  Impact of extrinsic incubation temperature and virus exposure on vector competence of Culex pipiens quinquefasciatus Say (Diptera: Culicidae) for West Nile virus. , 2007, Vector borne and zoonotic diseases.

[548]  Jeffrey S. Hall,et al.  Serologic evidence of West Nile virus exposure in North American mesopredators. , 2007, The American journal of tropical medicine and hygiene.

[549]  West Nile virus activity--United States, 2006. , 2007, MMWR. Morbidity and mortality weekly report.

[550]  K. Murray,et al.  Short communication Characteristics of an outbreak of West Nile virus encephalomyelitis in a previously uninfected population of horses , 2006 .

[551]  M. Pavy,et al.  Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses. , 2006, Antiviral research.

[552]  M. Schmidt,et al.  Molecular epidemiology of West Nile Virus in humans. , 2006, Developments in biologicals.

[553]  R. Bowen,et al.  NATURAL AND EXPERIMENTAL WEST NILE VIRUS INFECTION IN FIVE RAPTOR SPECIES , 2006, Journal of wildlife diseases.

[554]  J. B. Case,et al.  Acute encephalitis, polyarthritis, and myocarditis associated with West Nile virus infection in a dog. , 2006, Journal of veterinary internal medicine.

[555]  M. Rossmann,et al.  A structural perspective of the flavivirus life cycle , 2005, Nature Reviews Microbiology.

[556]  Jamie A. Blow,et al.  An Update on the Potential of North American Mosquitoes (Diptera: Culicidae) to Transmit West Nile Virus , 2005, Journal of medical entomology.

[557]  West Nile virus activity--United States, January 1-December 1, 2005. , 2005, MMWR. Morbidity and mortality weekly report.

[558]  L. Stark,et al.  WEST NILE VIRUS INFECTION IN FARMED AMERICAN ALLIGATORS (ALLIGATOR MISSISSIPPIENSIS) IN FLORIDA , 2005, Journal of wildlife diseases.

[559]  B. Tucker,et al.  Eastern cottontail rabbits (Sylvilagus floridanus) develop West Nile virus viremias sufficient for infecting select mosquito species. , 2005, Vector borne and zoonotic diseases.

[560]  K. Karaca,et al.  Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge. , 2004, Archives of virology. Supplementum.

[561]  C. Mandl,et al.  A novel principle of attenuation for the development of new generation live flavivirus vaccines. , 2004, Archives of virology. Supplementum.

[562]  L. V. Zlobina,et al.  West Nile virus and other zoonotic viruses in Russia: examples of emerging-reemerging situations. , 2004, Archives of virology. Supplementum.

[563]  T. Kreil.  West Nile virus: recent experience with the model virus approach. , 2004, Developments in biologicals.

[564]  Possible dialysis-related west nile virus transmission--Georgia, 2003. , 2004, MMWR. Morbidity and mortality weekly report.

[565]  D. Champ,et al.  Equine vaccine for West Nile virus. , 2003, Developments in biologicals.

[566]  N. Komar.  West Nile virus: epidemiology and ecology in North America. , 2003, Advances in virus research.

[567]  Jeffery A. Meyer,et al.  Repellency and efficacy of a 65% permethrin spot-on formulation for dogs against Aedes aegypti (Diptera: Culicidae) mosquitoes. , 2003, Veterinary therapeutics : research in applied veterinary medicine.

[568]  M. Turell,et al.  Wicking Assays for the Rapid Detection of West Nile and St. Louis Encephalitis Viral Antigens in Mosquitoes (Diptera: Culicidae) , 2003, Journal of medical entomology.

[569]  Daniel R. O’Leary,et al.  Epidemic/epizootic West Nile virus in the United States : guidelines for surveillance, prevention, and control. 3rd revision , 2003 .

[570]  E. Gould,et al.  Phylogeny and molecular epidemiology of West Nile and Kunjin viruses. , 2002, Current topics in microbiology and immunology.

[571]  C. Franceschi,et al.  Numerical and functional alterations of circulating gammadelta T lymphocytes in aged people and centenarians. , 2002, Journal of leukocyte biology.

[572]  Intrauterine West Nile virus infection--New York, 2002. , 2002, MMWR. Morbidity and mortality weekly report.

[573]  Update: Investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion--Michigan, 2002. , 2002, MMWR. Morbidity and mortality weekly report.

[574]  James R. Miller,et al.  Early season crow mortality as a sentinel for West Nile virus disease in humans, northeastern United States. , 2002, Vector borne and zoonotic diseases.

[575]  M. Turell,et al.  Potential vectors of West Nile virus in North America. , 2002, Current topics in microbiology and immunology.

[576]  John S Brownstein,et al.  Spatial analysis of West Nile virus: rapid risk assessment of an introduced vector-borne zoonosis. , 2002, Vector borne and zoonotic diseases.

[577]  M. Eidson.  "Neon needles" in a haystack: the advantages of passive surveillance for West Nile virus. , 2001, Annals of the New York Academy of Sciences.

[578]  S. Nesathurai,et al.  The Rehabilitation of people with traumatic brain injury , 2000 .

[579]  Z. Hubálek,et al.  West Nile fever--a reemerging mosquito-borne viral disease in Europe. , 1999, Emerging infectious diseases.

[580]  M. Dombovy,et al.  Rehabilitation outcomes in encephalitis--a retrospective study 1990-1997. , 1999, Brain injury.

[581]  J. Farber,et al.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.

[582]  J. Montgomery.  Physical therapy for traumatic brain injury , 1995 .

[583]  F. Guirakhoo,et al.  The interactions of the flavivirus envelope proteins: implications for virus entry and release. , 1994, Archives of virology. Supplementum.

[584]  N. Katz.  Cognitive rehabilitation : models for intervention in occupational therapy , 1992 .

[585]  W. Reeves,et al.  Bionomics and ecology of Culex tarsalis and other potential mosquito vector species. , 1990 .

[586]  N. Karabatsos,et al.  Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. , 1989, The Journal of general virology.

[587]  B. Mcintosh,et al.  Epidemics of West Nile and Sindbis viruses in South Africa with Culex (Culex) univittatus Theobald as vector. , 1976 .

[588]  D. Kipling,et al.  Annals of the New York Academy of Sciences Age-related Aspects of Human Igm B Cell Heterogeneity , 2022 .

[589]  James C. Kile,et al.  Serologic survey of cats and dogs during an epidemic of West Nile virus infection in humans , 2022 .

[590]  Nile Virus Infection Among Turkey Breeder , 2022 .

[591]  J. P. Durand,et al.  West Nile outbreak in horses in southern France, 2000: the return after 35 years. , 2001, Emerging infectious diseases.